Commentary on the GUARDIAN registry evaluating donor heart preservation outcomes during transport with different static cold storage–based systems.

Review of a US national database assessing heart transplantation outcomes among patients bridged with ECMO according to whether they were extubated at the time of transplant.

A national observational study based on the UNOS database analyzing how the new heart transplant allocation system in the United States has reshaped the use of temporary mechanical circulatory support devices and its impact on early post-transplant survival.

1st Cardiac Transplantation Symposium held in A Coruña, within the 9th Congress of the Spanish Transplantation Society, focusing on donation, recipient selection, preservation, mechanical circulatory support, and new strategies to improve outcomes after heart transplantation.

A new ISHLT consensus document addresses graft dysfunction within the first 72 hours after transplantation.

Retrospective observational study assessing the incidence of Impella malrotation in patients with cardiogenic shock and its potential association with clinical complications and early prognosis.

A retrospective, multicentre study from 9 centres in China evaluating 181 patients treated with a novel durable ventricular assist device featuring a fully magnetically levitated centrifugal pump and an ultrathin, highly flexible driveline designed to reduce local trauma at the exit site and, consequently, infection.

Observational cohort study analysing the impact of implementing a heart transplantation programme based on controlled donation after circulatory death on clinical outcomes from the time of inclusion on the waiting list.

This article provides an excellent overview of the historical development of cardiac xenotransplantation (transplantation using organs from other species) and clearly outlines the key concepts required to understand the current state of this technique.

This single-center retrospective observational study evaluates the impact of an initial strategy based on microaxial flow support with Impella® devices, comparing percutaneous models (Impella 2.5®/CP®) with high-flow devices surgically implanted via the axillary approach (Impella 5.0®/5.5®), and their effect on clinical stabilization, access to delayed surgery, and early survival in patients with post-infarction ventricular septal defect (VSD).